Ambassador Mark Dybul argues that America has forgotten the core insight of the Marshall Plan: supporting other countries’ economic growth creates markets for American businesses, and supporting global health produces better drugs for Americans.

Jessica Sacher has spent a decade studying the natural predators of bacteria, crafting cures for bacterial infections resistant to all known antibiotics.

Charlie Petty brings a VC's mindset to problems in global health by making venture investments into companies launching products with outsized benefits to public health.

Brian Finrow wants to make antibodies and other protein drugs a hundredfold or a thousandfold cheaper than other companies do today—ushering in a world of cheaper, safer, and more effective drugs.

Meri Beckwith wants "to give biotechs the ability to think and act more like tech companies" as his company, Lindus Health, disrupts the $100 billion/yr clinical trials industry.